
Kelly J Walkovich MD
Assistant Professor, Pediatrics & Communicable Diseases, University of Michigan Medical School
Join to View Full Profile
1500 E Medical Center Dr7th Floor Cs Mott Childrens HospitalAnn Arbor, MI 48109
Phone+1 734-936-9814
Fax+1 215-590-2204
Dr. Walkovich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of MichiganFellowship, Pediatric Hematology/Oncology, 2008 - 2011
- Children's Hospital of PhiladelphiaResidency, Pediatrics, 2005 - 2008
- University of Michigan Medical SchoolClass of 2005
Certifications & Licensure
- MI State Medical License 2008 - 2027
- PA State Medical License 2005 - 2008
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia Start of enrollment: 2013 Jun 01
- Loratadine for Improvement of Bone Pain in Patients With Chronic Granulocyte-Colony Stimulating Factor (G-CSF) Use Start of enrollment: 2019 Jun 24
- Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death Start of enrollment: 2007 Feb 12
Roles: Contact
Publications & Presentations
PubMed
- Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: phase 2 ESCALATE trial.Akiko Shimamura, Alexey Maschan, Carolyn Bennett, Sujith Samarasinghe, Jason E Farrar
Blood Advances. 2025-08-12 - Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summary.Shanmuganathan Chandrakasan, Carl E Allen, Deepika Bhatla, John Carter, May Chien
Immunotherapy. 2025-05-01 - 1 citationsPerspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH).Leonard Naymagon, Philip Roehrs, Michelle Hermiston, James Connelly, Jeffrey Bednarski
Orphanet Journal of Rare Diseases. 2025-04-26
Professional Memberships
- Member
- Member
- Clinical Immunology SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: